I think another set of risks to the ongoing business success of Medibank post IPO have evolved during this long convulated sale process.
That is, that a significant portion of policy holders as well as the general public are angry about how the whole IPO has been handled.
I have spoken to a lot of policy holders and many are planning to go elsewhere after the float as a sort of protest to their anticipated allocations in the IPO.
Here was a genuine opportunity to get both holders and the general public on board as long term customers and shareholders, but no, instead we had this confusing process, where it seems that their very client base and potential client base are going to be pissed off with some small offerings, so that overseas prop funds can get set in the stock,
how long are these funds going to stay in the stock if they smell a quick profit,
i cant complain, i got more stock than most, i am a policy holder, but if they think they can fob me off with a token allocation as said holder, i will be gone as a customer within the first week after the float.